The global Immunoglobulins market size was evaluated at US$ 11.3 billion in 2019. The market is expected to clock a notable 7.7% CAGR during the 2020-2027 to reach US$ 20.78 billion by 2027.
The global Immunoglobulins market is expected to witness a healthy growth in the near future, thanks to growing number of cancers and various other chronic illnesses. The market is also expected to be driven rising elderly population, rising health consciousness, growing penetration of healthcare facilities, and growing investment in product development. Major players in the global Immunoglobulins market are expected to invest in more R&D in the near future, due to expiry of various patents, technological advancements like 3D printing, and lowered costs due to global operations. Some key players in the global Immunoglobulins market are CSL Behring, Shire, Grifols, S.A., Kedrion Biopharma Inc, China Biologic Products Holdings, Inc, Octapharma.
The global Immunoglobulins market is witnessing a rising awareness for subcutaneous infusion. The easier method of its administration is expected to boost its adoption as compared to the intravenous injection. Additionally, the process is also witnessing a rising acceptance among medical practitioners and patients due to its proven safety and reliability. Moreover, for indications such as Guillain-Barre syndrome, dermatomyositis, relapsing-remitting multiple sclerosis, and stiff person syndrome, known as off-label indications, the demand is expected to grow. These common off-label indications are expected to create new opportunities for players in the global Immunoglobulins market.
Among various applications, the global Immunoglobulins market is expected to register the highest growth in the neurology segment. The primary immunodeficiency and higher dominance of idiopathic thrombocytopenic purpura are expected to drive the segment. Among various regions, the global Immunoglobulins market is expected to witness the highest growth in North America.
Autoimmune Diseases and Elderly Population to Drive Growth
The global Immunoglobulins market is expected to witness a significant growth in the near future, due to rising primary humoral immunodeficiency, autoimmune hemolytic anemia, immune thrombocytopenia purpura, multiple sclerosis, and kawasaki syndrome. Additionally, rheymatoid arthritis and systemic lupus erythematous are also on the rise. According to IDF or Immune Deficiency Foundation, nearly 83 people out 100,000 suffer from primary immunodeficiency. Moreover, the deficiency is rising among adults as well as children. The rising illnesses, growing access to healthcare, and growing consciousness are expected to be major impetus for growth in the global Immunoglobulins market.
Moreover, globally the elderly population is rising. The elderly population is at high-risk of various illnesses including autoimmune diseases. The growing population and growing expenditure on health in major markets like the US are expected to create significant opportunities for players in the Immunoglobulins market in the near future.
Hospitals to Remain the Key Service Providers in the Near Future
Based on end-user, the global Immunoglobulinss market is divided into clinic, hospitals, and homecare. Among these, the hospitals are expected to hold the majority of share in the near future. The segment is expected to surpass clinics and homecare as acceptance of advanced treatment and necessary hospitalization in many chronic illness cases drive demand. Moreover, the homecare segment is expected to witness considerable growth in the near future. Based on current trends, it can be concluded that many patients increasingly prefer the home-based care, perhaps due to low costs, and increased access to medical resources at fingertips. Moreover, uncertainties regarding insurance reimbursements can limit the expansion of the market during the forecast period.
The report analyzes and forecasts the immunoglobulins market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2020 to 2027. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of immunoglobulins, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major immunoglobulins companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of immunoglobulins upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of immunoglobulins and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global immunoglobulins market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the immunoglobulins market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of immunoglobulins market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Immunoglobulins Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Immunoglobulins Market Analysis and Forecast, 2016–2026
4.4.1. Global Immunoglobulins Market Value (US$ Mn) Projections
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
5.2. Regulatory Scenario by Region/globally
5.3. Pipeline Analysis
6. Global Immunoglobulins Market Analysis and Forecast, by Applications
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Immunoglobulins Market Value Forecast, by Applications, 2016–2026
6.3.1. Neurology
6.3.2. Immunology
6.3.3. Hematology
6.3.4. Others
6.4. Global Immunoglobulins Market Attractiveness by Applications
7. Global Immunoglobulins Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
7.3.1. Intravenous
7.3.2. Subcutaneous
7.3.3. Intramuscular
7.4. Global Immunoglobulins Market Attractiveness by Route of Administration
8. Global Immunoglobulins Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Immunoglobulins Market Value Forecast, by End-user, 2016–2026
8.3.1. Hospital
8.3.2. Clinic
8.3.3. Homecare
8.4. Global Immunoglobulins Market Attractiveness by End-user
9. Global Immunoglobulins Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Immunoglobulins Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Immunoglobulins Market Attractiveness, by Country/Region
10. North America Immunoglobulins Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
10.2.1. Neurology
10.2.2. Immunology
10.2.3. Hematology
10.2.4. Others
10.3. North America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
10.3.1. Intravenous
10.3.2. Subcutaneous
10.3.3. Intramuscular
10.4. North America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Homecare
10.5 North America Immunoglobulins Market Value Forecast, by Country, 2016–2026
10.5.1. US
10.5.2. Canada
10.6. North America Immunoglobulins Market Attractiveness Analysis
10.6.1. By Applications
10.6.2. By Route of Administration
10.6.3. By End-user
10.6.4. By Country
11. Europe Immunoglobulins Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Immunoglobulins Market Value Forecast by Applications, 2016–2026
11.2.1. Neurology
11.2.2. Immunology
11.2.3. Hematology
11.2.4. Others
11.3. Europe Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
11.3.1. Intravenous
11.3.2. Subcutaneous
11.3.3. Intramuscular
11.4. Europe Immunoglobulins Market Value Forecast, by End-user, 2016–2026
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Homecare
11.5. Europe Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Immunoglobulins Market Attractiveness Analysis
11.6.1. By Applications
11.6.2. By Route of Administration
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Immunoglobulins Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Immunoglobulins Market Value Forecast, by Applications, 2016–2026
12.2.1. Neurology
12.2.2. Immunology
12.2.3. Hematology
12.2.4. Others
12.3. Asia Pacific Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
12.3.1. Intravenous
12.3.2. Subcutaneous
12.3.3. Intramuscular
12.4. Asia Pacific Immunoglobulins Market Value Forecast, by End-user, 2016–2026
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Homecare
12.5. Asia Pacific Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Immunoglobulins Market Attractiveness Analysis
12.6.1. By Applications
12.6.2. By Route of Administration
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Immunoglobulins Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
13.2.1. Neurology
13.2.2. Immunology
13.2.3. Hematology
13.2.4. Others
13.3. Latin America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
13.3.1. Intravenous
13.3.2. Subcutaneous
13.3.3. Intramuscular
13.4. Latin America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Homecare
13.5. Latin America Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Immunoglobulins Market Attractiveness Analysis
13.6.1. By Applications
13.6.2. By Route of Administration
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Immunoglobulins Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
14.2.1. Neurology
14.2.2. Immunology
14.2.3. Hematology
14.2.4. Others
14.3. Latin America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
14.3.1. Intravenous
14.3.2. Subcutaneous
14.3.3. Intramuscular
14.4. Latin America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
14.4.1. Hospital
14.4.2. Clinic
14.4.3. Homecare
14.5. Latin America Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Latin America Immunoglobulins Market Attractiveness Analysis
14.6.1. By Applications
14.6.2. By Route of Administration
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Market Share Analysis by Company (2016)
15.3. Company Profiles
15.3.1. Shire
15.3.2. CSL Behring
15.3.3. Kedrion Biopharma Inc
15.3.4. Grifols, S.A.
15.3.5. Octapharma
15.3.6. China Biologic Products Holdings, Inc
15.3.7. Biotest AG
15.3.8. Sanquin
15.3.9. LFB SA
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers